PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.\', \'Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.\', \'ASH Research Collaborative, Washington, DC.\', \'Division of Hematologic Malignancies, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.\', \'Leukemia Program, Cleveland Clinic, Cleveland, OH.\', \'British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.\', \'Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.\', \'Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.\', \'Lung Cancer Program, Cleveland Clinic, Cleveland, OH.\', \'Department of Pediatric Hematology and Oncology, Medical Center Freiburg, Freiburg, Germany; and.\', \'Division of Hematology/Oncology, Department of Medicine, St. Michael\'s Hospital, Toronto, ON, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1182/bloodadvances.2020003170
?:doi
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 33278301
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33278301>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33278301>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all